Gout May Be Associated With Protective Effect Against Colorectal Cancer
Researchers assessed the relationship between gout and colorectal cancer in a cohort of veterans.
Colorectal Cancer
BEACON May Not Be the “Worst” Trial Ever, but a Key Question Remains
The one criticism that has persisted is the concern that a portion of patients on the control arm of the BEACON trial did not previously receive oxaliplatin.
Aspirin Use May Reduce Cancer, All-Cause Mortality in Seniors
Aspirin use three or more times per week tied to reduced all-cause, cancer, GI cancer, CRC mortality.
Testing for Genetic Variants Informed the Use of Cancer Risk Assessments
Genetic testing provided important information beyond personal and family history.
Long-Term Cancer Survivors Identify Ongoing Challenges Related to Ostomy Self-Management
In this study, researchers identified 8 common themes related to challenges patients experience with ostomy self-management.
Evidence Supports the Potential Use of KRAS(G12C) Inhibitor, Maybe Even in Combination
Preclinical and emerging clinical evidence support the possible use of AMG 510 as a single-agent KRAS (G12C) inhibitor, but preclinical evidence may also support the agent in combination.
Precision Medicine Transcends Tumor Type
Both DRUP and TAPUR have emphasized the importance of documenting the failures, as well as the successes, of the use of off-label therapies in cancer.
Enhanced Recovery After Surgery Program Leads to Less Opioid Use After Colorectal Cancer Surgery
A retrospective chart review conducted after implementing an ERAS program demonstrated that improved patient education led to less use of opioids in the immediate postoperative period.
Improving Patient Selection for Re-Resection of Metastatic Disease in Colorectal Cancer
In this study, the most common sites of recurrence following first resection of colorectal liver metastases were the liver (51%) followed by the lung (41%).
Cancer Screening Rates Lower Among Women With Diabetes
Rates for breast, cervical, colorectal cancer screening lower compared with women without diabetes.
Next post in General Oncology
